Meeting
2021 ASCO Quality Care Symposium
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
Authors
Bonnie Leung
BC Cancer, Vancouver, BC, Canada
Bonnie Leung, Aria Shokoohi, Zamzam Salam Al-Hashami, Sara Moore, Alexandra Pender, Selina K. Wong, Ying Wang, Jonn Wu, Cheryl Ho
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Access to Treatment and Supportive Care
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 93)
DOI
10.1200/JCO.2020.39.28_suppl.93
Abstract #
93
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Healthcare contact days for patients with stage IV non-small cell lung cancer (NSCLC) in Ontario: A population-based study.
First Author: Arjun Gupta
Poster
2023 ASCO Annual Meeting
Role of immunotherapy in stage IV non-small cell lung cancer with liver metastasis: A NCDB analysis.
First Author: Takefumi Komiya
Poster
2023 ASCO Annual Meeting
Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.
First Author: Howard Jinsoo Lee Jr.
Poster
2021 ASCO Annual Meeting
Analysis of patterns of care and benefit of thoracic radiotherapy for patients with stage IV NSCLC in the immunotherapy-era from a national hospital-based registry.
First Author: Michael Kharouta